MYLERAN vs TEMODAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. MYLERAN and TEMODAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYLERAN	TEMODAR
Rating	New	70/100
Pharmacy pays	—	~$206.51 /30
Type	RX	RX
Active ingredient	BUSULFAN	TEMOZOLOMIDE
Manufacturer	Waylis Therap	Merck Sharp Dohme
Dosage forms	Tablet	Capsule, Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	Boxed warning	None
Treats	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis	Glioblastoma, Melanoma

myleran temodar

Rating

New

70/100

Pharmacy pays

—

~$206.51 /30

Type

Active ingredient

BUSULFAN

TEMOZOLOMIDE

Manufacturer

Waylis Therap

Merck Sharp Dohme

Dosage forms

Tablet

Capsule, Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Glioblastoma, Melanoma

Frequently asked questions

What is the difference between Myleran and Temodar?

Myleran contains Busulfan, while Temodar contains Temozolomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.